3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202502436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, University of Jinan, Jinan, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MAP Kinase Signaling System, Antineoplastic Agents, Triterpenes. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Betulinic acid (BA) and its structural derivatives/analogs exhibit diverse biological activities particularly antitumor property, which has established them as attractive research topics in recent years. In the present work, 33 3‐substituted BA derivatives comprising 13 previously unreported ones were synthesized. Among them, a syringoyl analog (3‐deoxy‐3β‐syringoylamino‐betulinic acid [DSABA]) showed significantly enhanced cytostatic activity against specific tumor cell lines. Further in vitro antitumor evaluation revealed that DSABA induced cell death and G 0 /G 1 phase arrest, as well as inhibited the migration and invasion, of two breast cancer cell lines, and the in vivo antitumor efficacy was subsequently validated in an orthotopic autograft mouse model. Mechanistically, DSABA may exert its antitumor effect by modulating the RAS/RAF/MEK/ERK signaling pathway, as evidenced by a series of in vitro and in vivo experiments. In conclusion, this study has identified DSABA as a promising antitumor candidate, providing a foundation for the future investigation of related structural analogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, University of Jinan, Jinan, China.
- School of Biological Science and Technology, University of Jinan, Jinan, China.
- Institute of Translational Medicine, The Affiliated Hospital of Qingdao University, Qingdao Medical College, Qingdao University, Qingdao, China.
ORCID-Profile: Hua Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Su, P. W., Song, H., Wang, C., Shan, P., & Zhang, H. (2026). 3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502436
Vancouver
Liu H, Su PW, Song H, Wang C, Shan P, Zhang H. 3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502436
BibTeX
@article{Liu2026,
author = {Liu, Hu and Su, Pei-Wen and Song, Hui and Wang, Chao and Shan, Peipei and Zhang, Hua},
title = {3‐Deoxy‐3β‐syringoylamino‐betulinic acid Reduces Breast Tumor Growth and Lung Colonization, With Associated Downregulation of the RAS/RAF/MEK/ERK Pathway},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202502436}
}
EUVIMED